Clinical Trials in Seattle

Showing 3801-3820 of 6,103 trials

Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome

NCT02243579

This phase II trial studies how well pembrolizumab works in treating patients with stage IB-IVB mycosis fungoides or Sezary syndrome that has returned after a period of improvement or has not responded to at least one type of treatment. Monoclonal antibodies, such as pembrolizumab, may block cancer growth in different ways by targeting certain cells.

Recurrent Mycosis Fungoides and Sezary SyndromeRefractory Mycosis Fungoides and Sezary SyndromeStage IB Mycosis Fungoides and Sezary Syndrome AJCC v7+6 more

National Cancer Institute (NCI)24 participantsStarted Oct 2014

Palo Alto, California, United States • New Haven, Connecticut, United States • Tampa, Florida, United States +5 more locations

COMPLETEDPhase 3< 1 mile

A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma

NCT01170663

This is a Phase III randomized multicenter double-blind, placebo controlled trial evaluating the safety and efficacy of paclitaxel plus ramucirumab (IMC-1211B) drug product (DP) compared to paclitaxel plus placebo.

Gastric Cancer

Eli Lilly and Company665 participantsStarted Dec 2010

Burbank, California, United States • Los Angeles, California, United States • San Francisco, California, United States +164 more locations

Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome

A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma

Find Trials by Condition in Seattle

A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants

The Northwest Coalition for Primary Care Practice Support

Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia

Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma

Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions

One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease

Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD

Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes

The Prone Breast Radiation Therapy Trial

Firmagon (Degarelix) Intermittent Therapy

A Study in Participants With Moderate to Severe Psoriasis

An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy

A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia

Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1

A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)

A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer